Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma (Q84287955)
Jump to navigation
Jump to search
scientific article published on 06 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma |
scientific article published on 06 June 2011 |
Statements
Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma (English)
Steven M Sorscher
Albert Craig Lockhart
2735-6; author reply 2736-8